↓ Skip to main content

The effectiveness of endoscopic submucosal dissection followed by chemoradiotherapy for superficial esophageal cancer

Overview of attention for article published in Radiation Oncology, January 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news
1 news outlet
twitter
4 X users

Citations

dimensions_citation
91 Dimensions

Readers on

mendeley
60 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The effectiveness of endoscopic submucosal dissection followed by chemoradiotherapy for superficial esophageal cancer
Published in
Radiation Oncology, January 2015
DOI 10.1186/s13014-015-0337-4
Pubmed ID
Authors

Gen Kawaguchi, Ryuta Sasamoto, Eisuke Abe, Atsushi Ohta, Hiraku Sato, Kensuke Tanaka, Katsuya Maruyama, Motoki Kaizu, Fumio Ayukawa, Nobuko Yamana, Junyang Liu, Manabu Takeuchi, Masaaki Kobayashi, Hidefumi Aoyama

Abstract

BackgroundTo evaluate the risks and benefits of endoscopic submucosal dissection (ESD) in addition to chemoradiotherapy (CRT) for the treatment of superficial esophageal squamous cell carcinoma (SESCC).Methods and materialsWe retrospectively reviewed the treatment outcomes of 47 patients with SESCC treated between October 2000 and December 2011. Sixteen patients with invasion into the submucosal layer (T1b) or the muscularis mucosa (m3) with positive vascular invasion were treated with CRT after ESD (ESD-CRT group). The lymph node area was irradiated to a total dose of 40¿44 Gy and a boost radiation was administered if PET-positive lymph nodes or positive margins were observed. The remaining 31 patients received definitive CRT only (dCRT group).ResultsThe radiation field was significantly larger in the ESD-CRT group; the ¿long T¿ was used in 11 patients (35.4%) in the dCRT group and 15 (93.7%) in the ESD-CRT group (p¿=¿0.0001). The total radiation dose was smaller in the ESD-CRT group; 40 Gy was used in 10 patients (62.5%) in the ESD-CRT group and all but one patient in the dCRT group received ¿60 Gy (p¿=¿0.00001). The 3-year overall survival rates in the dCRT and ESD-CRT groups were 63.2% and 90.0% respectively (p¿=¿0.118). Recurrence developed in nine patients (29.0%) in the dCRT group and one (6.3%) in the ESD-CRT group. Local recurrence was observed in six patients (19%) in the dCRT group and none in the ESD-CRT-group (p¿=¿0.029). Pericardial effusion (¿ Grade 3) occurred in three patients (9.7%) in the dCRT group and none in the ESD-CRT group.ConclusionsESD followed by CRT is an effective and safe approach for SESCC at m3 or T1b. This combination of ESD and CRT improves the local control rate, and it could decrease the number of cardiac toxicities due to a radiation-dose reduction relative to CRT alone.

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 60 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 60 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 10 17%
Other 9 15%
Student > Master 9 15%
Student > Ph. D. Student 6 10%
Professor > Associate Professor 5 8%
Other 17 28%
Unknown 4 7%
Readers by discipline Count As %
Medicine and Dentistry 42 70%
Nursing and Health Professions 4 7%
Economics, Econometrics and Finance 1 2%
Agricultural and Biological Sciences 1 2%
Psychology 1 2%
Other 1 2%
Unknown 10 17%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 July 2019.
All research outputs
#2,631,786
of 22,783,848 outputs
Outputs from Radiation Oncology
#59
of 2,052 outputs
Outputs of similar age
#39,661
of 353,087 outputs
Outputs of similar age from Radiation Oncology
#2
of 74 outputs
Altmetric has tracked 22,783,848 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,052 research outputs from this source. They receive a mean Attention Score of 2.7. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 353,087 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 74 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.